Patent: 10,752,900
✉ Email this page to a colleague
Summary for Patent: 10,752,900
Title: | Oligonucleotides for modulating gene expression and uses thereof |
Abstract: | The present invention regards oligonucleotides for modulating the expression of a gene, in particular for modulating a gene responsible for a pathology of genetic, tumoural or viral origin. Moreover, the present invention relates to the use of said oligonucleotides, possibly chemically modified, for the treatment and/or the diagnosis of said diseases. |
Inventor(s): | Tonelli; Roberto (Granarolo Emilia, IT), Venturelli; Leonardo (Calderara di Reno, IT), Tortori; Andrea (Citerna, IT), Montemurro; Luca (Bologna, IT) |
Assignee: | BIOGENERA S.P.A. (Porretta Terme, IT) |
Application Number: | 16/009,303 |
Patent Claims: | see list of patent claims |
Details for Patent 10,752,900
Applicant | Tradename | Biologic Ingredient | Dosage Form | BLA | Approval Date | Patent No. | Expiredate |
---|---|---|---|---|---|---|---|
Recordati Rare Diseases, Inc. | ELSPAR | asparaginase | For Injection | 101063 | 01/10/1978 | ⤷ Try a Trial | 2032-02-24 |
>Applicant | >Tradename | >Biologic Ingredient | >Dosage Form | >BLA | >Approval Date | >Patent No. | >Expiredate |